Diabetic retinopathy (DR) may lead to vision-threatening complications in people living with
diabetes mellitus. Decades of research have contributed to our understanding of the …

Purpose Use of the electronic health record (EHR) has motivated the need for data
standardization. A gap in knowledge exists regarding variations in existing terminologies for …

Background. Diabetic retinopathy (DR) is a serious ophthalmopathy that causes blindness,
especially in the proliferative stage. However, the pathogenesis of its effect on endothelial …

Diabetes is a rapidly spreading disease. When the pancreas produces insufficient insulin or
the body cannot utilise it effectively. Diabetic Retinopathy (DR) and blindness are two major …

Proliferative retinopathies, such as neovascular age–related macular degeneration and
proliferative diabetic retinopathy, are a special health issue due to their contribution to …

Injectable hydrogels based on biopolymers, fabricated utilizing diverse chemical and
physical methodologies, exhibit exceptional physical, chemical, and biological properties …

Purpose To highlight the financial incentive to the physician of choosing an intravitreal anti-
vascular endothelial growth factor (VEGF)-based strategy for treating non-proliferative and …

Objective: To evaluate the frequencies of ocular comorbidities among patients with type II
diabetes, and the association with multiple systemic factors. Method: The retrospective …

Inflammation and endothelial activation play a pivotal role in development and progression
of diabetic retinopathy (DR), a vision-threatening complication of diabetes mellitus (DM) and …

Objective To evaluate the safety and efficacy of BI 1467335 in patients with non-proliferative
diabetic retinopathy (NPDR). Methods ROBIN is a Phase IIa, double-masked, randomised …